Xylem Inc. $XYL Shares Sold by Parallel Advisors LLC

Parallel Advisors LLC lessened its holdings in Xylem Inc. (NYSE:XYL) by 9.2% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 43,273 shares of the industrial products company’s stock after selling 4,391 shares during the period. Parallel Advisors LLC’s holdings in Xylem were worth $5,171,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. Commonwealth Retirement Investments LLC purchased a new position in shares of Xylem during the 4th quarter worth approximately $27,000. Wexford Capital LP acquired a new stake in Xylem during the 3rd quarter valued at $27,000. Global Assets Advisory LLC purchased a new position in Xylem during the first quarter worth $40,000. FWL Investment Management LLC purchased a new position in Xylem during the second quarter worth $43,000. Finally, Entrust Financial LLC acquired a new position in shares of Xylem in the fourth quarter worth $45,000. 87.96% of the stock is currently owned by institutional investors and hedge funds.

Xylem Stock Performance

Xylem stock opened at $120.82 on Tuesday. The firm has a market capitalization of $28.72 billion, a P/E ratio of 30.05, a PEG ratio of 1.75 and a beta of 1.03. The stock has a fifty day moving average price of $113.40 and a 200 day moving average price of $123.26. Xylem Inc. has a 52 week low of $105.29 and a 52 week high of $154.27. The company has a current ratio of 1.46, a quick ratio of 1.10 and a debt-to-equity ratio of 0.13.

Xylem (NYSE:XYL) last issued its quarterly earnings results on Tuesday, April 28th. The industrial products company reported $1.12 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.09 by $0.03. The firm had revenue of $2.12 billion for the quarter, compared to analyst estimates of $2.11 billion. Xylem had a return on equity of 11.26% and a net margin of 10.79%.The firm’s quarterly revenue was up 2.7% on a year-over-year basis. During the same period last year, the company earned $1.03 EPS. Xylem has set its FY 2026 guidance at 5.350-5.600 EPS. Equities research analysts anticipate that Xylem Inc. will post 5.51 earnings per share for the current year.

Xylem Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, June 25th. Stockholders of record on Thursday, May 28th were issued a dividend of $0.43 per share. This represents a $1.72 annualized dividend and a dividend yield of 1.4%. The ex-dividend date was Thursday, May 28th. Xylem’s dividend payout ratio is presently 42.79%.

Analysts Set New Price Targets

XYL has been the topic of a number of analyst reports. Royal Bank Of Canada increased their price objective on Xylem from $157.00 to $159.00 and gave the company an “outperform” rating in a research note on Thursday. Jefferies Financial Group raised shares of Xylem from a “hold” rating to a “buy” rating and raised their price target for the stock from $130.00 to $140.00 in a research note on Thursday, June 25th. Barclays lowered their price target on shares of Xylem from $156.00 to $154.00 and set an “overweight” rating for the company in a report on Wednesday, April 29th. Oppenheimer cut their price objective on shares of Xylem from $160.00 to $158.00 and set an “outperform” rating for the company in a research report on Wednesday, April 29th. Finally, JPMorgan Chase & Co. reduced their price objective on shares of Xylem from $170.00 to $160.00 and set an “overweight” rating on the stock in a research note on Thursday, April 16th. Eight research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. Based on data from MarketBeat.com, Xylem has a consensus rating of “Moderate Buy” and a consensus target price of $153.15.

Insider Activity at Xylem

In related news, Director Jerome A. Peribere bought 1,210 shares of the firm’s stock in a transaction that occurred on Monday, May 4th. The shares were acquired at an average cost of $116.61 per share, with a total value of $141,098.10. Following the completion of the transaction, the director owned 27,209 shares of the company’s stock, valued at approximately $3,172,841.49. The trade was a 4.65% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CAO Geri-Michelle Mcshane sold 4,269 shares of the business’s stock in a transaction that occurred on Thursday, May 7th. The shares were sold at an average price of $117.46, for a total transaction of $501,436.74. Following the completion of the sale, the chief accounting officer owned 3,605 shares of the company’s stock, valued at approximately $423,443.30. The trade was a 54.22% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 0.32% of the stock is currently owned by company insiders.

Xylem Profile

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.